1. "2017"
  2. "Molecular Pharmacology and Chemistry Program Faculty"
  3. "Adult Leukemia"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (13)
Groups
  1. Adult Leukemia (30)
  2. Center for Hematologic Malignancies (30)
  3. GSK Faculty (30)
  4. Molecular Pharmacology and Chemistry Program Faculty (30)
  5. Sloan Kettering Institute Faculty (30)
  6. Department of Medicine (29)

More Groups

People
  1. David Scheinberg (15)
  2. Jae Park (11)
  3. Renier Brentjens (9)
  4. Isabelle Riviere (8)
  5. Michel Sadelain (8)
  6. Brigitte Senechal (7)

More People

Years
  1. 2017 (30)
Publications
  1. Blood (3)
  2. Journal of Clinical Oncology (3)
  3. Leukemia (3)
  4. Clinical Cancer Research (2)
  5. Clinical Lymphoma, Myeloma and Leukemia (2)
  6. Haematologica (2)

More Publications

Publishers
  1. Nature Publishing Group (7)
  2. American Society of Clinical Oncology (3)
  3. American Society of Hematology (3)
  4. Elsevier Inc. (3)
  5. American Association for Cancer Research (2)
  6. Ferrata Storti Foundation (2)

More Publishers

Results (30)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Biomarkers associated with neurotoxicity in adult patients with relapsed or refractory B-ALL (R/R B-ALL) treated with CD19 CAR T cells
    Meeting Abstract

    Santomasso, B.; Park, J. H.; Riviere, I.; Mead, E.; Halton, E.; Diamonte, C.; Purdon, T.; Senechal, B.; Li, D.; Sadelain, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I trial of CD19-targeted EGFRt/19-28z/4-1BBL armored chimeric antigen receptor (CAR) modified T cells in patients with relapsed or refractory chronic lymphocytic leukemia
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X.; Senechal, B.; Bernal, Y.; Halton, E.; Diamonte, C.; Wang, Y.; Brentjens, R. J.; Sadelain, M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Durable long-term survival of adult patients with relapsed B-ALL after CD19 CAR (19-28z) T-cell therapy
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Mead, E.; Santomasso, B.; Halton, E.; Diamonte, C.; Bernal, Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase 2 study of actinium-225 ((225)Ac)-lintuzumab in older patients with previously untreated acute myeloid leukemia (AML) unfit for intensive chemotherapy
    Meeting Abstract

    Finn, L. E.; Levy, M.; Orozco, J. J.; Park, J. H.; Atallah, E.; Craig, M.; Perl, A. E.; Scheinberg, D. A.; Cicic, D.; Bergonio, G. R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • RNA regulators and the control of self-renewal
    Meeting Abstract

    Vu, L.; Prieto, C.; Amin, E. M.; Minuesa, G.; Chhangawala, S.; Vidal, M. C.; Krivtsov, A.; Chou, T.; Chow, A.; Barlowe, T.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • A randomized phase II trial of adjuvant galinpepimut-S, WT-1 analogue peptide vaccine, after multimodality therapy for patients with malignant pleural mesothelioma
    Journal Article

    Zauderer, M. G.; Tsao, A. S.; Dao, T.; Panageas, K.; Lai, W. V.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; Ginsberg, M. S.; Gomez, D.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
    Journal Article

    Vu, L. P.; Pickering, B. F.; Cheng, Y.; Zaccara, S.; Nguyen, D.; Minuesa, G.; Chou, T.; Chow, A.; Saletore, Y.; MacKay, M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes
    Journal Article

    Mathias, M. D.; Sockolosky, J. T.; Chang, A. Y.; Tan, K. S.; Liu, C.; Garcia, K. C.; Scheinberg, D. A.
    Leukemia (2017)

    Fulltext@MSK | Save
  • Therapeutic TCR mimic monoclonal antibodies to intracellular oncogenic proteins
    Meeting Abstract

    Scheinberg, D. A.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save